Work with thought leaders and academic experts in Parasitology

Companies can greatly benefit from working with experts in the field of Parasitology. These researchers can provide valuable insights and knowledge to enhance research and development efforts, improve product efficacy and safety, and contribute to innovation in the healthcare and pharmaceutical industries. Their expertise can also help companies in agriculture and veterinary sectors to develop effective strategies for parasite control and prevention. Additionally, collaborating with Parasitology experts can lead to the discovery of new treatment options, advancements in diagnostic techniques, and improved understanding of parasite-host interactions.

Researchers on NotedSource with backgrounds in Parasitology include Dr. Andrew Bernard, Ph.D., Dr. David Siderovski, Ph.D., Michael W Harman, Jeffrey Townsend, Lisa Marie Nelson, Ph.D., Dr. Justin Whalley, Ph.D, Claudia Colina Prisco Ph.D., Ishab Poudel, Murli Manohar, GULSUN AKDEMIR EVRENDILEK, Leo R Fitzpatrick PhD, Fariba Zad Bagher Seighalani, and Pranshu Sahgal, Ph.D..

Dr. David Siderovski, Ph.D.

Fort Worth
Professor of Computational Pharmacology; Chair of HSC SBS Dept. of Pharmacology & Neuroscience
Most Relevant Research Expertise
Parasitology
Other Research Expertise (25)
Regulator of G protein Signaling (RGS) proteins
Pharmacology
Molecular Biology
Cellular and Molecular Neuroscience
Molecular Medicine
And 20 more
About
Dr. David Siderovski is a renowned scientist and academic, with a career spanning over two decades. He received his Ph.D. in Medical Biophysics from the University of Toronto in 1997, where he specialized in signal transduction and cellular signaling pathways. After completing his doctorate, Dr. Siderovski held various faculty positions at prestigious universities, including the University of North Carolina at Chapel Hill, West Virginia University School of Medicine, and the University of North Texas Health Science Center. At these institutions, Dr. Siderovski has made significant contributions to the field of pharmacology through his research on G protein-coupled receptors (GPCRs) and RGS proteins, which are key regulators of GPCR cellular signaling. His work has helped to advance the understanding of RGS proteins and their roles in various diseases, including cancer, cardiovascular disorders, and neurological disorders. In addition to his research, Dr. Siderovski is also a dedicated educator and mentor. He has taught and mentored numerous undergraduate, graduate, and medical students, and has served as a mentor for postdoctoral fellows and junior faculty members. He is known for his passion and enthusiasm for science and his ability to inspire and guide the next generation of scientists. Dr. Siderovski has received numerous awards and honors for his contributions to the scientific community. He was the recipient of the Abel Award in 2004 from the American Society of Pharmacology & Experimental Therapeutics for his pioneering discoveries of the RGS proteins and the GoLoco motif. He has also served on editorial boards of several scientific journals (including a decade at *J.Biol.Chem.*) and has been a member of various scientific committees, NIH study section panels, and pharma/biotech advisory boards, including for Inspire, Wyeth, and BellBrook Labs. Overall, Dr. David Siderovski is a highly accomplished and respected scientist and educator, whose research has had a significant impact on the field of pharmacology. His dedication and passion for science continue to inspire and influence the next generation of researchers in this field.
Most Relevant Publications (1+)

94 total publications

A P-loop Mutation in Gα Subunits Prevents Transition to the Active State: Implications for G-protein Signaling in Fungal Pathogenesis

PLoS Pathogens / Feb 23, 2012

Bosch, D. E., Willard, F. S., Ramanujam, R., Kimple, A. J., Willard, M. D., Naqvi, N. I., & Siderovski, D. P. (2012). A P-loop Mutation in Gα Subunits Prevents Transition to the Active State: Implications for G-protein Signaling in Fungal Pathogenesis. PLoS Pathogens, 8(2), e1002553. https://doi.org/10.1371/journal.ppat.1002553

See Full Profile

Michael W Harman

East Greenwich, RI, Rhode Island, United States of America
Distinguished Subject Matter Expert & Leader in Medical Technologies.
Most Relevant Research Expertise
Parasitology
Other Research Expertise (13)
Bacteria & Cell Bio-Physics
Biomechanics
Infectious Diseases
Immunology
Microbiology
And 8 more
About
Highly skilled, energetic, and motivated professional empowered by over a decade of cross-disciplinary engineering and scientific applications experience. Presenting elegant solutions to prevalent biomedical challenges. Motivated by driving deliverable outcomes from complex research studies through effective leadership, active consulting work, and innovative problem-solving techniques. Seeking to make an immediate impact in a fast-paced biotechnology environment capitalizing on my advanced comprehension, continued professional growth, strategic product development expertise, and active network of personal connections across all areas of science, engineering, medicine, manufacturing and healthcare.
Most Relevant Publications (1+)

15 total publications

The Hybrid Histidine Kinase Hk1 Is Part of a Two-Component System That Is Essential for Survival of Borrelia burgdorferi in Feeding Ixodes scapularis Ticks

Infection and Immunity / Aug 01, 2011

Caimano, M. J., Kenedy, M. R., Kairu, T., Desrosiers, D. C., Harman, M., Dunham-Ems, S., Akins, D. R., Pal, U., & Radolf, J. D. (2011). The Hybrid Histidine Kinase Hk1 Is Part of a Two-Component System That Is Essential for Survival of Borrelia burgdorferi in Feeding Ixodes scapularis Ticks. Infection and Immunity, 79(8), 3117–3130. https://doi.org/10.1128/iai.05136-11

See Full Profile

Jeffrey Townsend

New Haven, CT, Connecticut, United States of America
Professor of Biostatistics and Ecology & Evolutionary Biology
Most Relevant Research Expertise
Parasitology
Other Research Expertise (52)
Evolutionary Genomics
Microbiology
Infectious Diseases
Genetics
Cell Biology
And 47 more
About
Jeffrey Townsend is a Professor of Organismic and Evolutionary Biology at Yale University. He received his Ph.D. from Harvard University in 2002 and his Sc.B. from Brown University in 1994. He has been a teacher at St. Ann's School and an Assistant Professor at the University of Connecticut. He is currently the Elihu Professor of Biostatistics at Yale University.
Most Relevant Publications (4+)

207 total publications

Retrospective Analysis of the 2014–2015 Ebola Epidemic in Liberia

The American Journal of Tropical Medicine and Hygiene / Apr 06, 2016

Atkins, K. E., Nyenswah, T. G., Galvani, A. P., Bawo, L., Yamin, D., Altice, F. L., Fallah, M., Medlock, J., Skrip, L., Wenzel, N. S., Ndeffo-Mbah, M. L., Pandey, A., & Townsend, J. (2016). Retrospective Analysis of the 2014–2015 Ebola Epidemic in Liberia. The American Journal of Tropical Medicine and Hygiene, 94(4), 833–839. https://doi.org/10.4269/ajtmh.15-0328

Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases

Parasites & Vectors / Dec 01, 2015

Hollingsworth, T. D., Adams, E. R., Anderson, R. M., Atkins, K., Bartsch, S., Basáñez, M.-G., Behrend, M., Blok, D. J., Chapman, L. A. C., Coffeng, L., Courtenay, O., Crump, R. E., de Vlas, S. J., Dobson, A., Dyson, L., Farkas, H., Galvani, A. P., Gambhir, M., … Zoueva, A. (2015). Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases. Parasites & Vectors, 8(1). https://doi.org/10.1186/s13071-015-1235-1

Cellular Superspreaders: An Epidemiological Perspective on HIV Infection inside the Body

PLoS Pathogens / May 08, 2014

Talbert-Slagle, K., Atkins, K. E., Yan, K.-K., Khurana, E., Gerstein, M., Bradley, E. H., Berg, D., Galvani, A. P., & Townsend, J. P. (2014). Cellular Superspreaders: An Epidemiological Perspective on HIV Infection inside the Body. PLoS Pathogens, 10(5), e1004092. https://doi.org/10.1371/journal.ppat.1004092

Probabilistic uncertainty analysis of epidemiological modeling to guide public health intervention policy

Epidemics / Mar 01, 2014

Gilbert, J. A., Meyers, L. A., Galvani, A. P., & Townsend, J. P. (2014). Probabilistic uncertainty analysis of epidemiological modeling to guide public health intervention policy. Epidemics, 6, 37–45. https://doi.org/10.1016/j.epidem.2013.11.002

See Full Profile

Lisa Marie Nelson, Ph.D.

Portland, Oregon, United States of America
PhD scientist with 17+ years drug development experience in biotech/pharma industry
Most Relevant Research Expertise
Parasitology
Other Research Expertise (6)
Market Assessment
Rare Genetic Disease
Cancer Pathogenesis
Pathology
Commercialization
And 1 more
About
Lisa Marie Nelson, Ph.D. is a highly accomplished professional with extensive experience in the fields of pathology, drug discovery and commercialization across all phases of development. She received her Ph.D. in Pathology from the University of North Carolina at Chapel Hill in 2005, where she specialized in parasitology and drug discovery research. Dr. Nelson is pursuing an MD in General Surgery from Oregon Health & Science University and holds a BS in Zoology from Oregon State University. After completing her doctorate, Dr. Nelson began her career as a Scientist/Senior Scientist at Shire Human Genetic Therapies. She then went on to hold various roles at the company, including Associate Director of Preclinical Discovery and Senior Medical Science Liaison. During this time, she gained extensive experience in drug development and medical affairs. In 2014, Dr. Nelson joined BIO Ventures for Global Health as a consultant, where she focused on developing and implementing global health programs. She then moved on to work as a Portfolio Development Manager at Ascendis Pharma, where she was responsible for identifying and evaluating potential drug candidates. Most recently, Dr. Nelson serves as the Global Medical Lead and Engagement Manager at Syneos Health, a leading healthcare consulting firm. In this role, she worked with pharmaceutical companies to develop and implement strategies for bringing new drugs to market. She also served as a consultant at The NemetzGroup LLC, providing expertise in medical affairs and drug development. Dr. Nelson is a dedicated and passionate professional with a strong commitment to improving global health. She is constantly seeking new opportunities to use her skills and expertise to make a positive impact in the healthcare industry.

See Full Profile

Claudia Colina Prisco Ph.D.

Scientist
Most Relevant Research Expertise
Parasitology
Other Research Expertise (14)
Neuroscience
G-protein coupled Receptors
ion channels and Lactate
Molecular Medicine
Drug Discovery
And 9 more
About
Resourceful and results-oriented Senior Biologist with 20+ years of experience in conducting groundbreaking research and leading cross-functional teams in the field of cellular biology. Proven expertise in designing and executing complex experiments, analyzing data, and interpreting results to drive scientific advancements. Adept at utilizing cutting-edge technologies and methodologies to solve challenging biological problems. Strong publication record with contributions to renowned journals. Skilled in project management, budgeting, and fostering collaborative relationships with diverse stakeholders. Seeking to leverage extensive background in the field and leadership experience to contribute to a dynamic research team focused on innovation and scientific excellence. Additionally proficient in mentoring undergraduate, graduate, postbaccalaureate and Postdoctoral fellows in Venezuela, Puerto Rico and US. Committed to driving impactful results through a combination of technical proficiency and collaborative leadership.
Most Relevant Publications (1+)

13 total publications

Evaluation of the Presence of a Thapsigargin-Sensitive Calcium Store in Trypanosomatids Using Trypanosoma evansi as a Model

Journal of Parasitology / Oct 01, 2004

Mendoza, M., Mijares, A., Rojas, H., Colina, C., Cervino, V., DiPolo, R., & Benaim, G. (2004). Evaluation of the Presence of a Thapsigargin-Sensitive Calcium Store in Trypanosomatids Using Trypanosoma evansi as a Model. Journal of Parasitology, 90(5), 1181–1183. https://doi.org/10.1645/ge-263r

See Full Profile

Ishab Poudel

Raleigh, North Carolina, United States of America
Dynamic and knowledgeable poultry scientist and veterinarian with extensive experience in poultry nutrition, disease and management.
Most Relevant Research Expertise
Parasitology
Other Research Expertise (6)
Poultry
Laying hen
Public Health, Environmental and Occupational Health
Infectious Diseases
Insect Science
And 1 more
About
Ishab Poudel is a veterinarian with a Ph.D. in Poultry Nutrition, showcasing a strong commitment to sustainable agriculture and disease control. With extensive research experience, including the development of nutritional strategies to enhance livestock sustainability and reduce environmental impacts.
Most Relevant Publications (2+)

12 total publications

A hyperendemic focus of Taenia solium transmission in the Banke District of Nepal

Acta Tropica / Dec 01, 2017

Sah, K., Poudel, I., Subedi, S., Singh, D. K., Cocker, J., Kushwaha, P., Colston, A., Donadeu, M., & Lightowlers, M. W. (2017). A hyperendemic focus of Taenia solium transmission in the Banke District of Nepal. Acta Tropica, 176, 78–82. https://doi.org/10.1016/j.actatropica.2017.07.022

A hyperendemic focus of porcine cystic echinococcosis in the Banke District of Nepal

Acta Tropica / Jan 01, 2020

Donadeu, M., Gauci, C. G., Poudel, I., Sah, K., Singh, D. K., Jabbar, A., & Lightowlers, M. W. (2020). A hyperendemic focus of porcine cystic echinococcosis in the Banke District of Nepal. Acta Tropica, 201, 105203. https://doi.org/10.1016/j.actatropica.2019.105203

See Full Profile

Murli Manohar

Boyce Thompson Institute, Cornell University
Most Relevant Research Expertise
Parasitology
Other Research Expertise (21)
Inter-specific interactions
Chemical signaling
Biopesticides
Plant Science
Ecology, Evolution, Behavior and Systematics
And 16 more
About
Instrumental in leading the development of Ascribe technology from start-up to successful execution. Skilled in identifying and capitalizing on emerging technologies and executing R&D strategic objectives to accelerate the product development process and increase customer centricity across different markets. Excel in overseeing cross-function projects with substantial R&D budgets to transform scientific discoveries into market-ready products. Tech leader and inventor with solid business acumen, holding patents for successful start-up and market-ready products. Expert at developing high-performing teams for commercializing new, differentiated, and disruptive products. Experienced researcher with effective communication and interpersonal skills; known for expanding business by collaborating with industry leaders, academic researchers, and contract research organizations. Passionate about driving innovation and delivering impactful results for business growth and market expansion. As a Ph.D. in Biochemistry, Molecular Biology, and Plant Science, I bring a strong background and expertise in agriculture and biopharmaceutical research. But more than that, I am driven by a deep passion for advancing Agtech, Foodtech, and Biotech solutions. My mission is to harness the power of nature to create sustainable and effective products that can enhance plant and human health.
Most Relevant Publications (1+)

30 total publications

Activation of Plant Innate Immunity by Extracellular High Mobility Group Box 3 and Its Inhibition by Salicylic Acid

PLOS Pathogens / Mar 23, 2016

Choi, H. W., Manohar, M., Manosalva, P., Tian, M., Moreau, M., & Klessig, D. F. (2016). Activation of Plant Innate Immunity by Extracellular High Mobility Group Box 3 and Its Inhibition by Salicylic Acid. PLOS Pathogens, 12(3), e1005518. https://doi.org/10.1371/journal.ppat.1005518

See Full Profile

GULSUN AKDEMIR EVRENDILEK

An experiences food scientist, industry consultant with process and produxt development, food safety quality assurance and complince with fod regulations
Most Relevant Research Expertise
Parasitology
Other Research Expertise (40)
innovative process technologies
seed treatment
food waste valorization
sensor technologies
Food Science
And 35 more
About
1. Founding, owning, and managing a research center, enabling collaboration with industries, small and medium enterprises (SMEs), and non-governmental organizations (NGOs) worldwide, working alongside scientists from diverse disciplines. 2. Successfully completing over 80 research and development projects in the food industry, from conceptualization to dissemination of results, as both a principal and co-investigator scientist. 3. Leading product development initiatives from concept to commercialization, involving expertise in formulation, sensory evaluation, shelf-life analysis, and quality assurance. 4. Effectively leading multi-level teams of food scientists, engineers, marketing professionals, and quality control experts, providing mentorship to junior scientists. 5. Leveraging analytical and problem-solving skills to tackle intricate challenges in product development and production consistently. 6. Possessing extensive knowledge and understanding of food safety regulations and standards, as well as international regulatory requirements. 7. Hands-on experience with safety regulations in food and environmental testing laboratories. 8. Proficiency in interpersonal communication, both written and verbal, gained through working in diverse fields locally and internationally, in both industry and academia. 9. Demonstrated excellence in delivering engaging presentations across all levels of the corporate hierarchy.
Most Relevant Publications (4+)

92 total publications

PULSED ELECTRIC FIELD TREATMENT OF LIQUID WHOLE EGG INOCULATED WITH SALMONELLA ENTERITIDIS

Journal of Food Safety / Apr 01, 2004

HERMAWAN, N., EVRENDILEK, G. A., DANTZER, W. R., ZHANG, Q. H., & RICHTER, E. R. (2004). PULSED ELECTRIC FIELD TREATMENT OF LIQUID WHOLE EGG INOCULATED WITH SALMONELLA ENTERITIDIS. Journal of Food Safety, 24(1), 71–85. Portico. https://doi.org/10.1111/j.1745-4565.2004.tb00376.x

CONCURRENT DETECTION OF ESCHERICHIA COLI O157:H7 AND SALMONELLA FROM A SINGLE ENRICHMENT IN 24 H

Journal of Food Safety / Jun 01, 2001

EVRENDILEK, G. A., RICHTER, E. R., & CHISM, G. W. (2001). CONCURRENT DETECTION OF ESCHERICHIA COLI O157:H7 AND SALMONELLA FROM A SINGLE ENRICHMENT IN 24 H. Journal of Food Safety, 21(2), 75–86. Portico. https://doi.org/10.1111/j.1745-4565.2001.tb00308.x

PULSED ELECTRIC FIELD PROCESSING OF FORMULATED RICE PUDDING

Journal of Food Safety / Feb 01, 2008

RATANATRIWONG, P., EVRENDILEK, G. A., & ZHANG, Q. H. (2008). PULSED ELECTRIC FIELD PROCESSING OF FORMULATED RICE PUDDING. Journal of Food Safety, 28(1), 126–141. Portico. https://doi.org/10.1111/j.1745-4565.2007.00100.x

Potential of pulsed electric field to control Aspergillus parasiticus, aflatoxin and mutagenicity levels: Sesame seed quality

Journal of Food Safety / Sep 14, 2020

Bulut, N., Atmaca, B., Akdemir Evrendilek, G., & Uzuner, S. (2020). Potential of pulsed electric field to control <scp>Aspergillus parasiticus</scp>, aflatoxin and mutagenicity levels: Sesame seed quality. Journal of Food Safety, 40(6). Portico. https://doi.org/10.1111/jfs.12855

See Full Profile

Leo R Fitzpatrick PhD

Greenwood , South Carolina, United States of America
GI Pharmacology and IBD Research Consultant
Most Relevant Research Expertise
Parasitology
Other Research Expertise (32)
Inflammatory Bowel Disease
Colitis
Arthritis
Surgery
Immunology
And 27 more
About
Please see my CV for details. I have 37 years of GI and IBD Research experience. This includes both industry and academic experience.
Most Relevant Publications (2+)

89 total publications

Bacillus Coagulans GBI-30 (BC30) improves indices of Clostridium difficile-Induced colitis in mice

Gut Pathogens / Jan 01, 2011

Fitzpatrick, L. R., Small, J. S., Greene, W. H., Karpa, K. D., & Keller, D. (2011). Bacillus Coagulans GBI-30 (BC30) improves indices of Clostridium difficile-Induced colitis in mice. Gut Pathogens, 3(1), 16. https://doi.org/10.1186/1757-4749-3-16

Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-Induced colitis following vancomycin withdrawal in mice

Gut Pathogens / Oct 01, 2012

Fitzpatrick, L. R., Small, J. S., Greene, W. H., Karpa, K. D., Farmer, S., & Keller, D. (2012). Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-Induced colitis following vancomycin withdrawal in mice. Gut Pathogens, 4(1). https://doi.org/10.1186/1757-4749-4-13

See Full Profile

Pranshu Sahgal, Ph.D.

Cell and Molecular biologist in cancer biology
Most Relevant Research Expertise
Parasitology
Other Research Expertise (17)
Cancer Biology
Cancer Signaling
Cancer Genomics
Drug Discovery and Development
Cell Biology
And 12 more
About
·         Cell and Molecular Biologist with a robust background in translational research, specializing in identifying novel molecular biomarkers, drug targets, and mechanism of action for advancing early cancer diagnosis and targeted cancer treatment. ·         Recognized for a proven track record of scientific innovation, evidenced by: ○        15+ scientific papers (6 as first/co-first author) having direct clinical development implications; 800+ citations. ○        20+ new collaborations; Presentations of scientific data in 10+ national/international conferences. ○        $350,000 as personal grant award acquisition from 10 foundations. ·         Exemplary collaborator and communicator with deep expertise in latest culture models, molecular biology techniques, assay development and Good Laboratory Practice (GLP). Demonstrated ability to effectively manage multiple projects, exhibiting exceptional organizational skills and keen attention to detail, leveraging innovative thinking to drive research forward. ·         Certified Medical Affairs Specialist with an understanding of clinical study and trials, contributing to regulatory submissions and fostering relationships with Key Opinion Leaders (KOLs), Contract Research Organizations (CROs), and other key stakeholders.
Most Relevant Publications (1+)

20 total publications

Structural and antigenic variance between novel influenza A/H1N1/2009 and influenza A/H1N1/2008 viruses

The Journal of Infection in Developing Countries / Nov 26, 2009

Saxena, S. K., Mishra, N., Saxena, R., Swamy, M. A., Sahgal, P., Saxena, S., Tiwari, S., Mathur, A., & Nair, M. P. (2009). Structural and antigenic variance between novel influenza A/H1N1/2009 and influenza A/H1N1/2008 viruses. The Journal of Infection in Developing Countries, 4(01), 001–006. https://doi.org/10.3855/jidc.546

See Full Profile

Example Parasitology projects

How can companies collaborate more effectively with researchers, experts, and thought leaders to make progress on Parasitology?

Development of Novel Antiparasitic Drugs

By collaborating with a Parasitology expert, pharmaceutical companies can develop new and more effective antiparasitic drugs. This can help in the treatment of various parasitic infections and improve patient outcomes.

Improving Diagnostic Techniques

Academic researchers in Parasitology can work with diagnostic companies to improve existing diagnostic techniques for detecting parasitic infections. This can lead to more accurate and efficient diagnosis, enabling timely treatment and control measures.

Parasite Control in Agriculture

Companies in the agriculture sector can collaborate with Parasitology researchers to develop effective strategies for parasite control in livestock and crops. This can help in reducing economic losses and improving productivity.

Vector-Borne Disease Prevention

Collaboration with Parasitology experts can aid companies in developing strategies for the prevention and control of vector-borne diseases. This can include the development of insecticides, vaccines, and vector control measures.

Understanding Parasite-Host Interactions

Companies can benefit from collaborating with Parasitology researchers to gain a deeper understanding of parasite-host interactions. This knowledge can be applied to develop targeted therapies and interventions.